Moreover, galectin-3 is required for microglia-mediated brain inflammation (Nomura et al., 2017; Siew et al., 2019), while the suppression of galectin-3 ameliorates microglia-mediated pathogenesis by decreasing NFκB activation (Siew et al., 2019). The gene discussed is NFKB1; the disease is inflammatory response.